Navigation Links
Ferring Donates US$3 Million to the Royal Textile Academy of Bhutan

SAINT PREX, Switzerland, July 31 /PRNewswire/ -- Frederik Paulsen, Chairman of Ferring Pharmaceuticals, a pharmaceutical company with presence in all major European markets and in the US, announced a US$3 million donation to the Royal Textile Academy of Bhutan. This money will be used to fund the creation and development of a new cultural centre in the Bhutanese capital of Thimphu.

Bhutan is globally renowned for the beauty of its textiles, designed and created along traditional lines by local Bhutanese weavers. The Academy will provide educational programmes, research and exhibitions aimed at both raising the international profile of Bhutanese textiles and improving the livelihood of the weavers who make them.

Speaking at the official presentation of the grant to the Royal Textile Academy, and in the presence of Her Majesty Ashi Sangay Choden Wangchuck, the Queen of Bhutan, Frederik Paulsen said:

"It is the sincere hope of all of us at Ferring that this grant will go some way towards contributing to the future success of the Royal Textile Academy and the future prosperity of Bhutan. The Academy will act as a focal point for both education and a variety of cultural events. It will include a new, state-of-the-art museum, a textile weaving academy and a conservation centre. It is hoped that the Academy will become a destination for tourists as well as students from all over the world. Both marketing and technical assistance will be provided to the weavers of Bhutan."

Her Majesty Ashi Sangay Choden Wangchuck, in response to Frederik Paulsen, said:

"I sincerely thank Dr. Paulsen and Ferring Pharmaceuticals for the great support they have shown to the Academy. This grant will not only benefit the people of Bhutan, especially our weavers, but will also enrich our cultural and economic development. Establishing the Royal Textile Academy is a dream that many of us in Bhutan share. I am confident that with continued support and guidance, we will succeed in creating a dynamic institution that will ensure that the textile arts of Bhutan continue to flourish into the next century."

About Ferring

Ferring Pharmaceuticals is a Swiss-based research driven, specialty biopharmaceutical group active in global markets. The company identifies, develops and markets innovative products in the areas of endocrinology, gastroenterology, gynaecology, fertility and urology. In recent years Ferring has expanded beyond its traditional European base and has operations in over 40 countries. To learn more about Ferring or its products please visit

SOURCE Ferring Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Ferring Announces $10,000 Grand Prize Winner of 2007 My Little Miracle Essay Contest
2. Ferring Pharmaceuticals EUFLEXXA(TM) to Serve as Sponsor for Sprint Force America Masters Track Club
3. Increase in Diagnostic Imaging Fueled by Self-Referring Doctors
4. Ferring Pharmaceuticals EUFLEXXA(R) to Serve as a Sponsor for the Babolat World Tennis Classic
5. Dr. Jan Linhart Now Offerring Unique Laser Teeth Whitening System
6. Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
7. Ferring Pharmaceuticals Announces Immediate Availability of Degarelix for the Treatment of Advanced Prostate Cancer
8. Frost & Sullivan Accolade for Ferring Pharmaceuticals
9. Educating referring clinicians about advanced imaging leads to drop in imaging exams
10. Ferring Pharmaceuticals and RESOLVE: The National Infertility Association Join Together to Launch Nurse Liaison Program
11. ALL: Boston Archdiocese Reportedly on Track for Abortion Referring Venture
Post Your Comments:
(Date:11/25/2015)... ... ... “While riding the bus, I saw a passenger in a wheelchair drenched from ... a convenient and comfortable way to protect them from bad weather, so I invented ... during cold or inclement weather. In doing so, it ensures that the user remains ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... An unlikely combination ... in a way for homeless people to have a more dignified and comfortable ... initiative whereby they are repurposing plastic bags into sleeping mats for the homeless. ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... focused on providing comprehensive solutions involving adult stem cell therapies to patients with ... deemed the “Regenestem” name as a Registered Trademark (RTM). , Organizations are required ...
(Date:11/24/2015)... ... 2015 , ... Genesis Chiropractic Software helps practice owners automate ... between the practice owner and the patient that automatically manages all five aspects ... Click here to learn more. , According to Dr. Brian ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , November 25, 2015 Kitov ... ) (TASE: KTOV), a biopharmaceutical company focused on the ... various clinical conditions, today announced the closing of its ... Shares ( ADSs ), each representing 20 ordinary shares ... 3,158,900 ADSs. The ADSs and warrants were issued in ...
(Date:11/25/2015)... , Nov. 25, 2015 Allergan ... pharmaceutical company, and Rugen Therapeutics, a start-up  biotechnology ... for unmet CNS disorders and funded by the ... they have entered into an exclusive collaboration to ... for Autism Spectrum Disorders (ASD) and Obsessive Compulsive ...
(Date:11/25/2015)... Israel , November 25, 2015 ... "New Investors"), pursuant to which BioLight and the New ... IOPtima Ltd. subsidiary ("IOPtima") via a private placement. The ... of its innovative IOPtimate™ system used in the treatment ... approval pathway process for the IOPtimate™ system with the ...
Breaking Medicine Technology: